17β-Estradiol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes

Journal of Endocrinology

Volumn 202, Issue 1, 2009, Pages 131-139

  Tagawa, Noriko ^a   Yuda, Ryosuke ^a   Kubota, Sayaka ^a   Wakabayashi, Midori ^a   Yamaguchi, Yuko ^a   Kiyonaga, Daisuke ^a   Mori, Natsuko ^a   Minamitani, Erika ^a   Masuzaki, Hiroaki ^b   Kobayashi, Yoshiharu ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; DEHYDROCORTICOSTERONE; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TAMOXIFEN; ENZYME INHIBITOR;

ACETYLATION; ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; ENZYME ACTIVATION; ENZYME INHIBITION; EPIMERIZATION; ESTROGEN ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WISTAR RAT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYME SPECIFICITY; ENZYMOLOGY; MICROSOME; MOUSE; RODENT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; ESTRADIOL; MALE; MICE; MICROSOMES; RATS; RATS, WISTAR; RECEPTORS, ESTROGEN; RODENTIA; SUBSTRATE SPECIFICITY;

EID: 67650756609     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0021     Document Type: Article

References (72)

1. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC & Simpson ER 1981 Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. Journal of Clinical Endocrinology and Metabolism 53 412-417.
2. Alberts P, Engblom L, Edling N, Forsgren M, Klingstrom G, Larsson C, Ronquist-Nii Y, Ohman B & Abrahmsen L 2002 Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45 1528-1532.
3. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M et al. 2003 Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144 4755-4762.
4. Andrews RC, Rooyackers O & Walker BR 2003 Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 88 285-291.
5. Atanasov AG, Nashev LG, Schweizer RA, Frick C & Odermatt A 2004 Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Letters 571 129-133.
6. Barf T, Vallgarda J, Emond R, Haggstrom C, Kurz G, Nygren A, Larwood V, Mosialou E, Axelsson K, Olsson R et al. 2002 Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1. Journal of Medicinal Chemistry 45 3813-3815.
7. Berger J, Tanen M, Elbrecht A, Hermanowski-Vosatka A, Moller DE, Wright SD & Thieringer R 2001 Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity. Journal of Biological Chemistry 276 12629-12635.
8. Beutler E & Morrison M 1967 Localization and characteristics of hexose 6-phosphate dehydrogenase (glucose dehydrogenase). Journal of Biological Chemistry 242 5289-5293.
9. Bjorntorp P & Rosmond R 2000 Obesity and cortisol. Nutrition 16 924-936.
10. Bublitz C & Steavenson S 1988a The pentose phosphate pathway in the endoplasmic reticulum. Journal of Biological Chemistry 263 12849-12853.
11. Bublitz C & Steavenson S 1988b The use of glucose dehydrogenase to monitor the integrity of microsomes. Biochimica et Biophysica Acta 965 90-92.
12. Chou JY, Matern D, Mansfield BC & Chen YT 2002 Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Current Molecular Medicine 2 121-143.
13. Chrousos GP & Gold PW 1992 The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. Journal of the American Medical Association 267 1244-1252.
14. Desbriere R, Vuaroqueaux V, Achard V, Boullu-Ciocca S, Labuhn M, Dutour A & Grino M 2006 11Beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity 14 794-798.
15. Deslypere JP, Verdonck L & Vermeulen A 1985 Fat tissue: a steroid reservoir and site of steroid metabolism. Journal of Clinical Endocrinology and Metabolism 61 564-570.
16. Dieudonne MN, Sammari A, Dos Santos E, Leneveu MC, Giudicelli Y & Pecquery R 2006 Sex steroids and leptin regulate 11beta-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities. Journal of Steroid Biochemistry and Molecular Biology 99 189-196.
17. Evinger AJ III & Levin ER 2005 Requirements for estrogen receptor alpha membrane localization and function. Steroids 70 361-363.
18. Falkenstein E, Tillmann HC, Christ M, Feuring M & Wehling M 2000 Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacological Reviews 52 513-556.
19. Folkerd EJ & James VH 1983 Aromatization of steroids in peripheral tissues. Journal of Steroid Biochemistry 19 687-690.
20. Haarbo J, Marslew U, Gotfredsen A & Christiansen C 1991 Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40 1323-1326.
21. Hall JM, Couse JF & Korach KS 2001 The multifaceted mechanisms of estradiol and estrogen receptor signaling. Journal of Biological Chemistry 276 36869-36872.
22. Hautanen A, Raikkonen K & Adlercreutz H 1997 Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males. Journal of Internal Medicine 241 451-461.
23. Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS et al. 2005 11Beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. Journal of Experimental Medicine 202 517-527.
24. Hewitt KN,Walker EA & Stewart PM2005 Minireview: hexose-6-phosphate dehydrogenase and redox control of 11{beta}-hydroxysteroid dehydrogenase type 1 activity. Endocrinology 146 2539-2543.
25. Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, Adachi K, Morishige K, Ohmichi M, Matsuzawa Y & Murata Y 2000 Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. Journal of Biological Chemistry 275 11404-11411.
26. Hosfield DJ,Wu Y, Skene RJ, HilgersM, Jennings A, Snell GP & Aertgeerts K 2005 Conformational flexibility in crystal structures of human 11beta-hydroxysteroid dehydrogenase type I provide insights into glucocorticoid interconversion and enzyme regulation. Journal of Biological Chemistry 280 4639-4648.
27. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S et al. 2000 Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. PNAS 97 12735-12740.
28. Kahn BB & Flier JS 2000 Obesity and insulin resistance. Journal of Clinical Investigation 106 473-481.
29. Kobayashi Y, Nishiguchi Y, Kiguchi T, Ninomiya I & Watanabe F 1987 An alternative metabolic pathway of 11-deoxycorticosterone in bovine adrenal in vitro: evidence for the presence of a pathway of 11-deoxycorticosterone oxidation at 19-position. Journal of Steroid Biochemistry 28 759-767.
30. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR et al. 1997 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoidinducible responses and resist hyperglycemia on obesity or stress. PNAS 94 14924-14929.
31. Labrie F, Belanger A, Cusan L & Candas B 1997 Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. Journal of Clinical Endocrinology and Metabolism 82 2403-2409.
32. Lakshmi V & Monder C 1988 Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 betahydroxysteroid dehydrogenase complex. Endocrinology 123 2390-2398.
33. Lavery GG, Walker EA, Draper N, Jeyasuria P, Marcos J, Shackleton CH, Parker KL, White PC & Stewart PM 2006 Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. Journal of Biological Chemistry 281 6546-6551.
34. Lineweaver H & Burk D 1934 The determination of enzyme dissociation constants. Journal of the American Chemical Society 56 658.
35. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ & Walker BR 2000 Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141 560-563.
36. Marcolongo P, Piccirella S, Senesi S, Wunderlich L, Gerin I, Mandl J, Fulceri R, Banhegyi G & Benedetti A 2007 The glucose-6-phosphate transporterhexose-6-phosphate dehydrogenase-11beta-hydroxysteroid dehydrogenase type 1 system of the adipose tissue. Endocrinology 148 2487-2495.
37. Maser E, Volker B & Friebertshauser J 2002 11 Beta-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase. Biochemistry 41 2459-2465.
38. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR & Flier JS 2001 A transgenic model of visceral obesity and the metabolic syndrome. Science 294 2166-2170.
39. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ et al. 2003 Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. Journal of Clinical Investigation 112 83-90.
40. Mayo-Smith W, Hayes CW, Biller BM, Klibanski A, Rosenthal H & Rosenthal DI 1989 Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology 170 515-518.
41. McCormick KL, Wang X & Mick GJ 2006 Evidence that the 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1) is regulated by pentose pathway flux. Studies in rat adipocytes and microsomes. Journal of Biological Chemistry 281 341-347.
42. Montague CT & O'Rahilly S 2000 The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49 883-888.
43. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ & Seckl JR 2001 Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. Journal of Biological Chemistry 276 41293-41300.
44. Nomura S, Fujitaka M, Sakura N & Ueda K 1997 Circadian rhythms in plasma cortisone and cortisol and the cortisone/cortisol ratio. Clinica Chimica Acta 266 83-91.
45. Pappas TC, Gametchu B & Watson CS 1995 Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB Journal 9 404-410.
46. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC & Grino M 2002 Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. Journal of Clinical Endocrinology and Metabolism 87 2701-2705.
47. Paulsen SK, Pedersen SB, Fisker S & Richelsen B 2007 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity 15 1954-1960.
48. Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A & Pedersen SB 2008 Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen. Obesity 16 731-735.
49. Pedersen SB, Borglum JD, Eriksen EF & Richelsen B 1991 Nuclear estradiol binding in rat adipocytes. Regional variations and regulatory influences of hormones. Biochimica et Biophysica Acta 1093 80-86.
50. Pedersen SB, Borglum JD, Moller-Pedersen T & Richelsen B 1992 Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes. Molecular and Cellular Endocrinology 85 13-19.
51. Perel E, Daniilescu D, Kindler S, Kharlip L & Killinger DW 1986 The formation of 5 alpha-reduced androgens in stromal cells from human breast adipose tissue. Journal of Clinical Endocrinology and Metabolism 62 314-318.
52. Phillips DI, Barker DJ, Fall CH, Seckl JR, Whorwood CB, Wood PJ & Walker BR 1998 Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome? Journal of Clinical Endocrinology and Metabolism 83 757-760.
53. Price T, Aitken J, Head J, Mahendroo M, Means G & Simpson E 1992 Determination of aromatase cytochrome P450 messenger ribonucleic acid in human breast tissue by competitive polymerase chain reaction amplification. Journal of Clinical Endocrinology and Metabolism 74 1247-1252.
54. Razandi M, Pedram A, Greene GL & Levin ER 1999 Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Molecular Endocrinology 13 307-319.
55. Rebuffe-Scrive M, Krotkiewski M, Elfverson J & Bjorntorp P 1988 Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 67 1122-1128.
56. Revankar CM, Cimino DF, Sklar LA, Arterburn JB & Prossnitz ER 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 1625-1630.
57. Rodbell M 1964 Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. Journal of Biological Chemistry 239 375-380.
58. Rodriguez-Cuenca S, Monjo M, Proenza AM & Roca P 2005 Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu. American Journal of Physiology. Endocrinology and Metabolism 288 E200-E207.
59. Romanelli A, St-Denis JF, Vidal H, Tchu S & van deWerve G 1994 Absence of glucose uptake by liver microsomes: an explanation for the complete latency of glucose dehydrogenase. Biochemical and Biophysical Research Communications 200 1491-1497.
60. Sawada H, Hayashibara M, Hara A & Nakayama T 1980 A possible functional relationship between microsomal aromatic aldehyde-ketone reductase and hexose-6-phosphate dehydrogenase. Journal of Biochemistry 87 985-988.
61. Sawada H, Hara A, Hayashibara M, Nakayama T, Usui S & Saeki T 1981 Microsomal reductase for aromatic aldehydes and ketones in guinea pig liver. Purification, characterization, and functional relationship to hexose-6-phosphate dehydrogenase. Journal of Biochemistry 90 1077-1085.
62. Schneider G, Kirschner MA, Berkowitz R & Ertel NH 1979 Increased estrogen production in obese men. Journal of Clinical Endocrinology and Metabolism 48 633-638.
63. Simpson ER, Ackerman GE, Smith ME & Mendelson CR 1981 Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticosteroids. PNAS 78 5690-5694.
64. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE & Hennekens CH 1991 Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. New England Journal of Medicine 325 756-762.
65. Stewart PM & Krozowski ZS 1999 11 Beta-hydroxysteroid dehydrogenase. Vitamins and Hormones 57 249-324.
66. Tagawa N, Ikariko N, Fukumura K & Kobayashi Y 2007 Development of an enzyme-linked immunosorbent assay for serum 11-dehydrocorticosterone in rat and mouse. Biological and Pharmaceutical Bulletin 30 403-409.
67. Tchernof A, Despres JP, Belanger A, Dupont A, Prud'homme D, Moorjani S, Lupien PJ & Labrie F 1995 Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism 44 513-519.
68. Thomas P, Pang Y, Filardo EJ & Dong J 2005 Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 624-632.
69. Wajchenberg BL 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews 21 697-738.
70. Walker BR, Connacher AA, Lindsay RM, Webb DJ & Edwards CR 1995 Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. Journal of Clinical Endocrinology and Metabolism 80 3155-3159.
71. Walker EA, Clark AM, Hewison M, Ride JP & Stewart PM 2001 Functional expression, characterization, and purification of the catalytic domain of human 11-beta -hydroxysteroid dehydrogenase type 1. Journal of Biological Chemistry 276 21343-21350.
72. Zhang J, Osslund TD, Plant MH, Clogston CL, Nybo RE, Xiong F, Delaney JM & Jordan SR 2005 Crystal structure of murine 11 beta-hydroxysteroid dehydrogenase 1: an important therapeutic target for diabetes. Biochemistry 44 6948-6957.